Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer
申请人:THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
公开号:US20160002175A1
公开(公告)日:2016-01-07
A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
Pyrimidine-2,4-diamine derivatives for treatment of cancer
申请人:THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
公开号:US10174029B2
公开(公告)日:2019-01-08
A compound of formula I,
or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
式 I 的化合物、
或其药学上可接受的盐。该化合物可用于治疗癌症或其他可从抑制 MTH1 中获益的疾病。
PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER
申请人:Thomas Helledays Stiftelse För Medicinsk Forskning